Ishikawa K, Arita T, Shimoda K, Hagino Y, Shiraishi N, Kitano S
Surgery Division, Arita Gastrointestinal Hospital, 1-2-6 Maki, Oita, 870-0924, Japan.
Surg Endosc. 2005 Aug;19(8):1151-4. doi: 10.1007/s00464-004-2076-8. Epub 2005 May 26.
This study evaluated the indications and outcome for transanal endoscopic surgery (TES) used to manage rectal carcinoid tumor as compared with those of conventional transanal local resection (TAR).
The retrospective study subjects were 28 patients with rectal carcinoid tumor treated by TES (n = 17) or TAR (n = 11) between January 1995 and December 2001. Patient and tumor characteristics, operative results, and postoperative outcomes were compared between the two groups.
The distance from the anal verge to the distal tumor margin in the TES group (range, 4-12 cm; median, 6.8 cm) was significantly greater than in the TAR group (range, 3-6 cm; median, 4.5 cm) (p = 0.001). The median tumor diameter was 5.5 mm (range, 3-11 mm) in the TES group and 5.0 mm (range, 3-8 mm) in the TAR group, showing no statistical difference. Microscopically, resected specimens in both groups were typical carcinoid tumors restricted to the submucosal layer. No recurrence was noted in either group.
Whereas TES is useful for patients with small rectal carcinoid tumor of typical histology within the submucosal layer in the upper and middle rectum, TAR is effective for accessing the lower rectum.
本研究评估了经肛门内镜手术(TES)与传统经肛门局部切除术(TAR)用于治疗直肠类癌肿瘤的适应证及疗效。
回顾性研究对象为1995年1月至2001年12月期间接受TES(n = 17)或TAR(n = 11)治疗的28例直肠类癌肿瘤患者。比较两组患者的临床和肿瘤特征、手术结果及术后结局。
TES组从肛缘至肿瘤远端边缘的距离(范围4 - 12 cm;中位数6.8 cm)显著大于TAR组(范围3 - 6 cm;中位数4.5 cm)(p = 0.001)。TES组肿瘤直径中位数为5.5 mm(范围3 - 11 mm),TAR组为5.0 mm(范围3 - 8 mm),差异无统计学意义。显微镜下,两组切除标本均为局限于黏膜下层的典型类癌肿瘤。两组均未发现复发。
对于中高位直肠黏膜下层典型组织学类型的小直肠类癌肿瘤患者,TES有效;而TAR对于低位直肠病变有效。